Treatment gap for people living with epilepsy in Madagascar.
Using an indirect assessment technique we assessed the epilepsy treatment gap (ETG) in Madagascar. We estimate the ETG in Madagascar to be 92%. However, given the sociological, economic and sanitary conditions of the country, it is likely that the true ETG is even higher than our estimate. Our study also documents the lack of access to treatment for patients in this developing country. The indirect method could be used to assess the treatment gaps of other chronic medical conditions.
Université de Limoges, IFR 145 GEIST, Institut de Neurologie Tropicale, EA 3174 Neuroepidémiologie Tropicale et Comparée, Limoges, F-87025, France.
Voa
V
Ratsimbazafy
Rakotobe
R
Andrianabelina
Sonia
S
Randrianarisona
Pierre-Marie
PM
Preux
Peter
P
Odermatt
D000927:Anticonvulsants / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D001463:Barbiturates / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D003695:Delivery of Health Care / Q000592:standards*; D003906:Developing Countries; D003975:Diazepam / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006297:Health Services Accessibility / Q000592:standards; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D008270:Madagascar / Q000453:epidemiology; D010634:Phenobarbital / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use
D000927:Anticonvulsants; D001463:Barbiturates; D006993:Hypnotics and Sedatives; C027712:butobarbital; D003975:Diazepam; D010634:Phenobarbital